StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) income statement

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)

Close on Nov 18, 2026Market cap $288.48MP/E –Yield –

Benitec Biopharma Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-33.2%

Financial strength

Current ratio
34.00
Debt to equity
–
Debt to assets
–
Cash to current liabilities
3367.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
1.63
Dividend yield
–

See a number that looks wrong?